The company
A clinical-stage medical technology company developing FlowMaker, an intracardiac pump for the treatment of advanced heart failure.
The funding
FineHeart, based in Pessac, France, announced €35M in Series C financing on January 9, 2026.
FineHeart Raises €35M Series C+
FineHeart raised €35M in a Series C round announced on January 9, 2026. A clinical-stage medical technology company developing FlowMaker, an intracardiac pump for the treatment of advanced heart failure.
Round size
€35MStage
Series C+Headquarters
FranceAnnounced
Jan 9, 202603 / Related rounds
Related funding rounds
Series C+ · Travel
Mews
A provider of a cloud-native hospitality operating system that manages property operations, reservations, payments, housekeeping, and revenue for hotels.
Series C+ · Healthtech
Oviva
Oviva provides personalized dietary advice combined with digital tools to help individuals change their habits and improve their health.